Lianxiaxiaopi Granules

· Tasly Pharmaceutical Group Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lianxiaxiaopi Granules, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome [Phase 3]